K. Towlson

537 total citations
16 papers, 369 citations indexed

About

K. Towlson is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, K. Towlson has authored 16 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in K. Towlson's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). K. Towlson is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). K. Towlson collaborates with scholars based in United Kingdom, United States and Australia. K. Towlson's co-authors include D I Marks, Nigel H. Russell, Jamie Cavenagh, Charles Craddock, Rachel Pearce, Tim Littlewood, Gordon Cook, Antonio Pagliuca, A. L. Dolan and Bronwen E. Shaw and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

K. Towlson

16 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Towlson United Kingdom 10 183 123 106 89 84 16 369
Carme Pedro Spain 12 185 1.0× 62 0.5× 43 0.4× 84 0.9× 27 0.3× 27 342
Marion Strullu France 11 84 0.5× 61 0.5× 36 0.3× 55 0.6× 88 1.0× 29 277
Giacomo Loseto Italy 11 53 0.3× 158 1.3× 30 0.3× 87 1.0× 52 0.6× 24 343
Fabienne Trullemans Belgium 12 190 1.0× 114 0.9× 56 0.5× 20 0.2× 38 0.5× 20 362
Lochie Teague New Zealand 12 169 0.9× 36 0.3× 24 0.2× 18 0.2× 97 1.2× 26 322
Amir Steinberg United States 8 98 0.5× 89 0.7× 21 0.2× 27 0.3× 26 0.3× 73 221
Hans‐Jürgen Hurtz Germany 4 111 0.6× 109 0.9× 25 0.2× 94 1.1× 24 0.3× 5 272
Anita J. Kumar United States 11 61 0.3× 95 0.8× 19 0.2× 60 0.7× 74 0.9× 37 245
Per Frisk Sweden 9 44 0.2× 47 0.4× 39 0.4× 43 0.5× 57 0.7× 27 221
Ranjan Tiwari India 11 105 0.6× 186 1.5× 31 0.3× 47 0.5× 35 0.4× 38 384

Countries citing papers authored by K. Towlson

Since Specialization
Citations

This map shows the geographic impact of K. Towlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Towlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Towlson more than expected).

Fields of papers citing papers by K. Towlson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Towlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Towlson. The network helps show where K. Towlson may publish in the future.

Co-authorship network of co-authors of K. Towlson

This figure shows the co-authorship network connecting the top 25 collaborators of K. Towlson. A scholar is included among the top collaborators of K. Towlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Towlson. K. Towlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Malladi, Ram, Andy Peniket, Tim Littlewood, et al.. (2008). Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML. Bone Marrow Transplantation. 43(9). 709–715. 22 indexed citations
2.
Shaw, Bronwen E., G J Mufti, Stephen Mackinnon, et al.. (2008). Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplantation. 42(12). 783–789. 76 indexed citations
3.
Gilleece, Maria, Rachel Pearce, David C. Linch, et al.. (2008). The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study. Hematology. 13(2). 119–127. 16 indexed citations
4.
Feyler, Sylvia, H. Miles Prince, Rachel Pearce, et al.. (2007). The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplantation. 40(5). 443–450. 71 indexed citations
5.
Gilleece, Maria, K. Towlson, M.T. Wilson, et al.. (2007). 203: Vaccination against infection after haemopoietic stem cell transplant. Biology of Blood and Marrow Transplantation. 13(2). 75–75. 1 indexed citations
6.
Cook, Gordon, Richard E. Clark, Charles Crawley, et al.. (2006). The Outcome of Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia in First Remission Who Were Initially Refractory to First Induction Chemotherapy. Biology of Blood and Marrow Transplantation. 12(3). 293–300. 7 indexed citations
7.
Chantry, Andrew, John A. Snowden, Charles Craddock, et al.. (2006). Long-Term Outcomes of Myeloablation and Autologous Transplantation of Relapsed Acute Myeloid Leukemia in Second Remission: A British Society of Blood and Marrow Transplantation Registry Study. Biology of Blood and Marrow Transplantation. 12(12). 1310–1317. 11 indexed citations
8.
Shaw, Bronwen E., G J Mufti, Stephen Mackinnon, et al.. (2006). Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.. Blood. 108(11). 3660–3660. 1 indexed citations
10.
Russell, Nigel H., Richard Szydlo, Shaun R. McCann, et al.. (2004). The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland. British Journal of Haematology. 124(4). 499–503. 9 indexed citations
11.
Shaw, Bronwen E., Karl S. Peggs, Jennifer M. Bird, et al.. (2003). The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. British Journal of Haematology. 123(5). 886–895. 19 indexed citations
13.
Dobbs, N, C.J. Twelves, Antonio J. Ramírez, et al.. (1993). Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancer. European Journal of Cancer. 29(12). 1707–1711. 6 indexed citations
14.
Rubens, R.D., K. Towlson, Antonio J. Ramírez, et al.. (1992). Appropriate chemotherapy for palliating advanced cancer.. BMJ. 304(6818). 35–40. 32 indexed citations
15.
Towlson, K. & R.D. Rubens. (1992). Quality of Life: Outcome Evaluation. Journal of Palliative Care. 8(3). 22–24. 4 indexed citations
16.
Towlson, K., et al.. (1984). Domperidone and levodopa in Parkinson's disease.. British Journal of Clinical Pharmacology. 18(6). 959–962. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026